PulteGroup, Inc. (P1HM34)
B3 Stock Exchange · Brazil · prices in BRL · close of 26 Oct 2026
Key indicators
| Last close | BRL 655.82 |
|---|---|
| 52-week range | 583.38 – 725.48 |
| Return, 1 month / 3 months | +8.1% / +1.1% |
| Return, 1 year / 3 years | −1.1% / +75.8% |
| Trend | Uptrend |
| RSI (14) | 90 |
| Volatility (1 year) | 23.3% |
| Worst drawdown (1 year) | -19.5% |
| Average daily value traded | 0.00M BRL |
| Dividend yield | 3.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
PulteGroup is a homebuilding company based in the United States that designs and constructs new homes for buyers across a range of ages and budgets. Its brands serve first-time buyers, move-up families and older adults looking for active lifestyle communities, and the company also provides mortgage financing and title services to its homebuyers. It operates in markets throughout the country, offering detached houses and attached homes in planned communities.
PulteGroup, Inc. is represented on the B3 Stock Exchange in Brazil by a Brazilian depositary receipt (BDR) under the code P1HM34, with its price quoted in Brazilian reais (BRL). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
PulteGroup, Inc. (P1HM34) trades on the B3 Stock Exchange in Brazil. It last closed at BRL 655.82 on 26 October 2026.
Its price-based Market X-Ray is 55 out of 100 (a fair price profile), ranking 609 of 1,455 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 1.1% and over the last three months it rose 1.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on B3 Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 56 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 2.7% | ||
| From 52-week high | -9.6% | ||
| Momentum | 51 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 1.1% | ||
| 6-month return | 8.6% | ||
| 12-month return, skipping the last month | -8.6% | ||
| Stability (higher is calmer) | 82 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 23.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -19.5% | ||
| Liquidity | 12 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.00M BRL | ||
| Zero-volume days | 96.7% | ||
| Income | 52 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 3.1% | ||
| Years with dividends | 6 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | +8.1% |
|---|---|
| 1 month | +8.1% |
| 3 months | +1.1% |
| 6 months | +8.6% |
| 1 year | −1.1% |
| 3 years | +75.8% |
| 5 years | +149.0% |
Signals
| 50-day / 200-day average | 626.02 / 638.56 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 3.95 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 14 Sep 2026 | USD 0.9073 |
| 15 Jun 2026 | USD 0.9411 |
| 16 Mar 2026 | USD 0.9378 |
| 15 Dec 2025 | USD 0.9805 |
| 15 Sep 2025 | USD 0.8238 |
| 16 Jun 2025 | USD 0.8347 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on B3 Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.